期刊文献+

左炔诺孕酮宫内缓释系统的临床应用分析 被引量:1

Clinical analysis of levonorgestrel intrauterine system
下载PDF
导出
摘要 目的:探讨放置左炔诺孕酮宫内缓释系统(LNG-IUS)的临床适应证、效果及副作用,为临床有效安全应用提供依据。方法:回顾性分析本中心近5年放置左炔诺孕酮宫内缓释系统共371例临床资料。结果:LNG-IUS的临床适应证主要有子宫腺肌症或子宫内膜异位症(49.3%)、月经过多或月经紊乱(17.5%)、子宫内膜病变(14.0%)、子宫内膜息肉术后(8.9%)、避孕(7.3%)等。放置LNG-IUS后痛经程度较术前减轻[VAS评分(3.2±1.3)分比(5.6±1.4)分;t=15.588,P<0.001]。月经过多治疗有效率达74.2%。LNG-IUS治疗子宫内膜病变的内膜病理转化率100%。子宫内膜息肉术后放置LNG-IUS 6个月子宫内膜厚度与术前差异有统计学意义[(0.5±0.1)cm比(0.8±0.3)cm;t=4.505,P<0.001)]。LNG-IUS的1、2、3年续用率分别为86.1%(261/303)、84.2%(170/202)、80.9%(89/110)。LNG-IUS放置后副作用主要有闭经(40.7%)、不规则阴道出血(39.6%)、腰部酸胀(9.4%)。结论:放置LNG-IUS在减轻痛经、减少月经量、治疗子宫内膜病变、预防子宫内膜息肉复发等方面有良好效果,长期持续使用率高。放置LNG-IUS术前应对患者进行充分咨询,知情选择提高依从性。 Objective:To explore the clinical indications,effect and side effects of levonorgestrel intrauterine system(LNG-IUS),and to provide the references for the effective and safe clinical application of LNG-IUS.Methods:A retrospective analysis on 371cases treated with LNG-IUS during the last 5years was conducted.Results:The main indications of the women with LNG-IUS inserted in clinic included adenomyosis/endometriosis(49.3%),menorrhagia(17.5%),endometrial lesions(14.0%),after transcervical resection of endometrial polyp(8.9%)and contraception(7.3%),etc.The dysmenorrhea of the women after LNG-IUS treatment relieved significantly,and the VAS score(3.2±1.3points)of the women after LNG-IUS treatment was significantly lower than that(5.6±1.4points)before treatment(t=15.588,P<0.001).The effective rate of LNG-IUS for treating the menorrhagia of the women was 74.2%.The pathological effective rate of LNG-IUS for treating the endometrial lesions was 100%.There was significant difference in the endometrial thickness(0.5±0.1cm vs.0.8±0.3cm)of the women between the LNG-IUS treatment for 6 months and before treatment(t=4.505,P<0.001).The continuation rate of LNG-IUS used of the women in 1-year,2-years,and 3-years after surgery were 86.1%(261/303),84.2%(170/202),and 80.9%(89/110),respectively.The main side effects of the women after LNG-IUS inserted were amenorrhea 40.7%,irregular vaginal bleeding 39.6%,and lumbar soreness 9.4%.Conclusion:LNG-IUS inserted of the women achieves good effect for treating their dysmenorrhea,menorrhagia and endometrial lesions,and for preventing their recurrence of endometrial polyp after transcervical resection.LNG-IUS has high continue use rate for a long time.The sufficient consultation and the informed choice of the women before LNG-IUS inserted should be done to improve their compliance.
作者 尹若昀 张巧 YIN Ruoyun;ZHANG Qiao(Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing,100730)
机构地区 北京医院
出处 《中国计划生育学杂志》 2023年第12期3020-3023,3029,共5页 Chinese Journal of Family Planning
关键词 左炔诺孕酮宫内缓释系统 避孕 痛经 月经过多 Levonorgestrel intrauterine system Contraception Dysmenorrhea Menorrhagia
  • 相关文献

参考文献5

二级参考文献38

  • 1Rutanen EM. Endometrial response to intrauterine release of levonorgestrel. Gynecol Forum, 1998, 3(1): 11-14.
  • 2Luukkainen T, Pakarinen P, Toivonen J. Progestin-releasing intrauterine system. Semi Reprod Med, 2001, 19(4): 355-363.
  • 3Zalel Y, Shulman A, Lidor A, et al. The local progestational efffect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow study. Hum Reprod, 2002, 17(11):2878-2880.
  • 4Guillebaud .I. The levnorgestrel intrauterine systemL: a clinical perspective from the UK. Ann N Y Acad Sci, 2003, 997(2): 185-193.
  • 5Backman T, Huhtala S, Luoto R, et al. Advance information improves improves user satisfaction with the levonorgestrel intrauterine system.Obstet Gynecol, 2002, 99(4): 608-613.
  • 6French R, Cowan F, Mansour D, et al. Hormonally impregnated intrauterine systems(IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev, 2001,(2):CD001776.
  • 7Backman T, Rauramo I, Huhtala S, et al. Pregancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol, 2004, 190(1):50-54.
  • 8Roy SN, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Saf, 2004, 27(2):75-90.
  • 9Xiao BL, Wu SC, Chong J, et al. Therapeutic effects of the lenonorgestrelrelesing intrauterina system in the treatment of idiopathic menorrhagia. Fertil Steril, 2003, 79(4):963-969.
  • 10Barrington JW, Arunkalivanan AS, Avdek-Fattah M. Compariso between the levonorgestrel intrauterine system (LNG-IUS)and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol, 2003, 108(1):72-74.

共引文献1476

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部